Journal article
Overview of the study protocols and statistical analysis plan for the Saline versus Plasma-Lyte 148 for Intravenous Fluid Therapy (SPLIT) research program
Sumeet K Reddy, Paul J Young, Richard W Beasley, Diane M Mackle, Shay P McGuinness, Colin J McArthur, Seton J Henderson, Laurence Weinberg, Craig J French, Neil R Orford, Michael J Bailey, Rinaldo Bellomo
CRITICAL CARE AND RESUSCITATION | AUSTRALASIAN MED PUBL CO LTD | Published : 2015
Abstract
BACKGROUND: 0.9% saline is the most commonly used intravenous (IV) fluid in the world but recent data raise the possibility that, compared with buffered crystalloid fluids such as Plasma-Lyte 148, the administration of 0.9% saline might increase the risk of developing acute kidney injury. OBJECTIVE: To provide an overview of the study protocols and statistical analysis plan for the six studies making up the (0.9% Saline v Plasma-Lyte 148 for Intravenous Fluid Therapy (SPLIT) research program. METHODS: The SPLIT study consists of six integrated clinical trials, including a double-blind, cluster, randomised, double-crossover study in intensive care unit patients, incorporating two nested studi..
View full abstractGrants
Funding Acknowledgements
All studies are investigator initiated and study analyses will be conducted independently of the funding organisations. Study A is primarily funded by a grant from the Health Research Council of New Zealand. The cost of Study B, Study C and Study F have been underwritten by the MRINZ. A funding application has been made to the Australian and New Zealand College of Anaesthetists for Study D. Study E will be funded by the Austin Hospital Intensive Care Trust Fund.